» Articles » PMID: 8875467

Drainage of CSF Through Lymphatic Pathways and Arachnoid Villi in Sheep: Measurement of 125I-albumin Clearance

Overview
Specialty Neurology
Date 1996 Aug 1
PMID 8875467
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

We investigated lymphatic drainage pathways of the central nervous system in conscious sheep and quantified the clearance of a cerebrospinal fluid (CSF) tracer into lymph and blood. In the first group of studies, 125I-HSA was injected into the lateral ventricles of the brain or into lumbar CSF and after 6 h, various lymph nodes and tissues were excised and counted for radioactivity. Multiple lymphatic drainage pathways of cranial CSF existed in the head and neck region defined by elevated 125I-HSA in the retropharyngeal/cervical, thymic, pre-auricular and submandibular nodes. Implicated in spinal CSF drainage were mainly the lumbar and intercostal nodes. In a second group of experiments, multiple cervical vessels and the thoracic duct were cannulated and lymph diverted from the animals. Transport of tracer through arachnoid villi was taken from recoveries in venous blood. Following intraventricular administration, the 6 h recoveries of 125I-HSA in the lymph (sum of cervical and thoracic duct) and blood were 8.2% +/- 3.0 and 12.5% +/- 4.5 respectively and at 22 h, 25.1% +/- 6.9 and 20.8% +/- 4.1 respectively. When 125I-HSA was injected into lumbar CSF, the 6 h recoveries of tracer in thoracic duct and blood were 11.6% +/- 2.7 and 16.3% +/- 3.7 respectively. Total lymph and blood recoveries were not significantly different in any experiment. We conclude that the clearance of 125I-HSA from the CSF is almost equally distributed between lymphatic and arachnoid villi pathways.

Citing Articles

Regulation of brain fluid volumes and pressures: basic principles, intracranial hypertension, ventriculomegaly and hydrocephalus.

Hladky S, Barrand M Fluids Barriers CNS. 2024; 21(1):57.

PMID: 39020364 PMC: 11253534. DOI: 10.1186/s12987-024-00532-w.


In-depth Mechanism, Challenges, and Opportunities of Delivering Therapeutics in Brain Using Intranasal Route.

Ghosh A, Majie A, Karmakar V, Chatterjee K, Chakraborty S, Pandey M AAPS PharmSciTech. 2024; 25(5):96.

PMID: 38710855 DOI: 10.1208/s12249-024-02810-0.


The anatomic basis of leptomeningeal metastasis.

Freret M, Boire A J Exp Med. 2024; 221(4).

PMID: 38451255 PMC: 10919154. DOI: 10.1084/jem.20212121.


Vascular Endothelial Growth Factor-C Treatment Enhances Cerebrospinal Fluid Outflow during Toxoplasma gondii Brain Infection but Does Not Improve Cerebral Edema.

Kovacs M, Babcock I, Royo Marco A, Sibley L, Kelly A, Harris T Am J Pathol. 2023; 194(2):225-237.

PMID: 38065361 PMC: 10835445. DOI: 10.1016/j.ajpath.2023.11.008.


Exit pathways of therapeutic antibodies from the brain and retention strategies.

Schellhammer L, Beffinger M, Salazar U, Laman J, Buch T, Vom Berg J iScience. 2023; 26(11):108132.

PMID: 37915602 PMC: 10616392. DOI: 10.1016/j.isci.2023.108132.